Published in PPAR Res on April 14, 2016
Sweet-P inhibition of glucocorticoid receptor β as a potential cancer therapy. Cancer Cell Microenviron (2016) 0.78
FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone. Endocrinology (2016) 0.77
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76
A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (1994) 11.50
RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell (1994) 8.71
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature (1992) 8.15
Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science (1991) 6.80
Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science (1996) 4.50
Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell (1993) 4.19
The role of C/EBP genes in adipocyte differentiation. J Biol Chem (1998) 3.30
Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood (1992) 2.62
A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem (2001) 2.21
Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci U S A (1995) 2.03
Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol (1997) 1.95
Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc Natl Acad Sci U S A (1992) 1.82
Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice. J Pharmacol Sci (2009) 1.71
TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal (2007) 1.47
Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol (2006) 1.46
FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol Cell Biol (1995) 1.45
The non-DNA-binding heterooligomeric form of mammalian steroid hormone receptors contains a hsp90-bound 59-kilodalton protein. J Biol Chem (1990) 1.36
Immunophilins and the nervous system. Nat Med (1995) 1.34
Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition (2012) 1.33
FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A. Oncogene (2009) 1.29
Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol Endocrinol (2010) 1.29
Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice. Basic Clin Pharmacol Toxicol (2009) 1.28
Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J Biol Chem (2007) 1.28
A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep (2003) 1.27
PPARγ and the global map of adipogenesis and beyond. Trends Endocrinol Metab (2014) 1.26
Tumor necrosis factor alpha inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins. Mol Cell Biol (2000) 1.19
Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene (2006) 1.19
Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem Biophys Res Commun (2004) 1.19
Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J Pharmacol Exp Ther (1999) 1.15
Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. J Biol Chem (1993) 1.13
Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ). J Biol Chem (2011) 1.13
Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells. J Biol Chem (2002) 1.08
Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins. Aging Cell (2015) 1.03
Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet. Cell Death Dis (2013) 1.02
FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis. J Neurosci Res (2004) 0.99
FK506 binding proteins: cellular regulators of intracellular Ca2+ signalling. Eur J Pharmacol (2013) 0.98
Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice. Endocrinology (2010) 0.98
Molecular mechanisms of adipocyte differentiation and inhibitory action of pref-1. Crit Rev Eukaryot Gene Expr (1997) 0.96
FK506 and the role of immunophilins in nerve regeneration. Mol Neurobiol (1997) 0.96
Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity (Silver Spring) (2013) 0.93
Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol (2008) 0.92
Non-FK506-binding protein-12 neuroimmunophilin ligands increase neurite elongation and accelerate nerve regeneration. J Neurosci Res (2005) 0.89
Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN. J Biol Chem (2014) 0.89
Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice. PLoS One (2014) 0.88
Factors influencing nerve regeneration in a trial of timcodar dimesylate. Neurology (2006) 0.87
The glucocorticoid receptor: cause of or cure for obesity? Am J Physiol Endocrinol Metab (2015) 0.87
Immunophilins, mTOR, and pharmacodynamic strategies for a targeted cancer therapy. Clin Cancer Res (2003) 0.86
Rapamycin Modulates Markers of Mitochondrial Biogenesis and Fatty Acid Oxidation in the Adipose Tissue of db/db Mice. J Biochem Pharmacol Res (2013) 0.84
FK506 and the role of the immunophilin FKBP-52 in nerve regeneration. Drug Metab Rev (1999) 0.84
Biliverdin reductase isozymes in metabolism. Trends Endocrinol Metab (2015) 0.84
Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus. Am J Physiol Endocrinol Metab (2012) 0.83
FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathway. Mol Endocrinol (2014) 0.83
FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ. Mol Endocrinol (2014) 0.82
Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52. J Med Chem (2012) 0.82
Overexpression of Glucocorticoid Receptor β Enhances Myogenesis and Reduces Catabolic Gene Expression. Int J Mol Sci (2016) 0.82
Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation. Pharmacol Res Perspect (2014) 0.80
Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer. Int J Endocrinol (2015) 0.78
Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer. PPAR Res (2017) 0.75
Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin. Antioxidants (Basel) (2022) 0.75